SCHEMBL32686008

SCHEMBL32686008

Cc1c(C(=O)N2CCOCC2)sc2cc(-c3ccc(=O)n(C)c3)ccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.47
HPGD P15428 6/20 0.44
ALDH1A1 P00352 6/20 0.41
CNR1 P21554 1/20 0.40
KDM4E B2RXH2 4/20 0.40
ALOX15 P16050 3/20 0.40
HSD17B10 Q99714 3/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
RAB9A P51151 5/20 0.39
NPC1 O15118 3/20 0.39
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
TAF1 P21675 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32686117 0.81 CES2 (0.49) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL32685937 0.80 CES2 (0.44) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL32686061 0.78 HPGD (0.56) CES2HPGDALDH1A1KDM4ERAB9A
SCHEMBL32686053 0.77 CES2 (0.42) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL32686052 0.77 CES2 (0.42) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL32686151 0.74 AKT1 (0.43) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL1609283 0.74 GPR35 (0.56) CES2HPGDALDH1A1CNR1KDM4E
SCHEMBL31221898 0.72 GPR35 (0.47) HPGDMKNK1MKNK2
SCHEMBL1608957 0.71 CES2 (0.55) CES2HPGDALDH1A1KDM4ENPC1
SCHEMBL31221985 0.70 BRD4 (0.37) ALDH1A1HSD17B10GAARAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709480-A1 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP claimed
EP-4709480-A1 5,6-FUSED BICYCLIC AMIDES AND COMPOSITIONS FOR USE AS 15-PROSTAGLANDIN DEHYDROGENASE MODULATORS Amgen Inc. (US) 2026-03-18 EP disclosed